Clinical bottom line
AI-enhanced imaging techniques, particularly those integrating cardiac magnetic resonance imaging (MRI) with advanced machine learning algorithms, show promising potential for early detection of radiation-induced cardiac fibrosis. These approaches improve sensitivity and specificity in identifying subclinical myocardial changes before overt clinical heart failure develops. However, current evidence is primarily from early-phase studies and requires further validation in larger cohorts. Incorporating AI-driven analysis into routine cardiac imaging could enable timely intervention and personalized management for patients at risk of radiation-induced cardiac injury.
What the evidence shows
Radiation-induced cardiac fibrosis is a delayed but serious complication of thoracic radiotherapy, contributing to morbidity and mortality. Conventional imaging modalities often detect fibrosis only after significant myocardial damage has occurred.
Zhang et al. (2018) reviewed advanced cardiac imaging modalities for radiation-induced injury, emphasizing the role of late gadolinium-enhanced MRI (LGE-MRI) in visualizing myocardial fibrosis. Ramirez et al. (2012) further detailed LGE-MRI’s utility in detecting and quantifying atrial fibrosis, underscoring its relevance to radiation-induced changes.
Masuodi et al. (2026) correlated cardiac MRI findings with radiation treatment planning CT scans, demonstrating that MRI can identify late-onset myocardial fibrosis in lung cancer patients post-radiotherapy, highlighting the modality’s diagnostic value.
Recent advances integrate AI algorithms with multi-modal imaging and clinical data to enhance early detection. Priya et al. (2026) described AI-enhanced cardiac risk prediction models that combine imaging features with clinical parameters, improving diagnostic accuracy and enabling earlier identification of fibrosis.
Alshammari et al. (date not specified) utilized cardiac MRI relaxometry techniques enhanced by AI to detect myocardial fibrosis at earlier stages than conventional imaging, suggesting improved sensitivity.
At the molecular level, Gu et al. (2024) identified METTL3 as a modulator of radiation-induced cardiac fibrosis via the Akt/mTOR pathway, providing potential imaging biomarkers for AI algorithms to target.
Caveats and uncertainty
Most AI-enhanced imaging studies remain in early or pilot phases, with limited sample sizes and heterogeneous patient populations.
Standardization of imaging protocols, AI model training, and validation across institutions is lacking, which may affect reproducibility and generalizability.
The clinical impact of earlier fibrosis detection on patient outcomes, including whether it alters management or prognosis, requires prospective evaluation.
Cost, accessibility, and integration of AI tools into existing radiology workflows pose practical challenges.
How this may change practice
Radiologists and cardiologists may increasingly incorporate AI-enhanced cardiac MRI and multi-modal imaging into surveillance protocols for patients receiving thoracic radiotherapy.
Early detection of radiation-induced fibrosis could prompt timely cardioprotective interventions, potentially mitigating progression to heart failure.
AI tools may facilitate personalized risk stratification and monitoring, optimizing resource allocation and follow-up intensity.
Ongoing research and clinical trials will be critical to establish standardized imaging and AI protocols, validate clinical utility, and guide implementation.